BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36446381)

  • 21. The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models.
    Butowt R; Meunier N; Bryche B; von Bartheld CS
    Acta Neuropathol; 2021 Jun; 141(6):809-822. PubMed ID: 33903954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys.
    Jiao L; Yang Y; Yu W; Zhao Y; Long H; Gao J; Ding K; Ma C; Li J; Zhao S; Wang H; Li H; Yang M; Xu J; Wang J; Yang J; Kuang D; Luo F; Qian X; Xu L; Yin B; Liu W; Liu H; Lu S; Peng X
    Signal Transduct Target Ther; 2021 Apr; 6(1):169. PubMed ID: 33895780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases.
    Mahalaxmi I; Kaavya J; Mohana Devi S; Balachandar V
    J Cell Physiol; 2021 Feb; 236(2):763-770. PubMed ID: 32697344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of SARS-CoV2 Entry Protein ACE2 in the Human Nose and Olfactory Bulb.
    Klingenstein M; Klingenstein S; Neckel PH; Mack AF; Wagner AP; Kleger A; Liebau S; Milazzo A
    Cells Tissues Organs; 2020; 209(4-6):155-164. PubMed ID: 33486479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
    Burks SM; Rosas-Hernandez H; Alejandro Ramirez-Lee M; Cuevas E; Talpos JC
    Brain Behav Immun; 2021 Jul; 95():7-14. PubMed ID: 33412255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the spread of SARS-CoV-2 and olfactory cell lineage impairment in close-contact infection Syrian hamster models.
    Ueha R; Ito T; Ueha S; Furukawa R; Kitabatake M; Ouji-Sageshima N; Uranaka T; Tanaka H; Nishijima H; Kondo K; Yamasoba T
    Front Cell Infect Microbiol; 2022; 12():1019723. PubMed ID: 36339331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological Involvements of SARS-CoV2 Infection.
    Gasmi A; Tippairote T; Mujawdiya PK; Gasmi Benahmed A; Menzel A; Dadar M; Bjørklund G
    Mol Neurobiol; 2021 Mar; 58(3):944-949. PubMed ID: 33064267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients.
    Pipolo C; Bottai D; Fuccillo E; Aronica E; Bruschi F; Bulfamante AM; Castellani L; Canevini MP; Chiumello D; Ferrari S; Martinelli C; Muttini S; Priori A; Saibene AM; Spoldi C; Tosi D; Zanusso G; Bulfamante GP; Felisati G
    PLoS One; 2022; 17(4):e0266740. PubMed ID: 35413071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain.
    Dey J; Alam MT; Chandra S; Gupta J; Ray U; Srivastava AK; Tripathi PP
    J Med Virol; 2021 Mar; 93(3):1296-1303. PubMed ID: 32964419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotropism of SARS-CoV-2: A Pathological Examination of Neurosurgical Specimens.
    Fujii T; Rennert RC; Hurth KM; Ward PM; Campan M; Mathew AJ; Dubeau L; Wallace WD; Liu CY; Russin JJ
    Neurosurgery; 2024 Feb; 94(2):379-388. PubMed ID: 37728367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olfactory immune response to SARS-CoV-2.
    Wellford SA; Moseman EA
    Cell Mol Immunol; 2024 Feb; 21(2):134-143. PubMed ID: 38143247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the olfactory bulb volume and morphology in patients with coronavirus disease 2019: can differences create predisposition to anosmia?
    Akkaya H; Kizilog Lu A; Dilek O; Belibag Li C; Kaya Ö; Yılmaz C; Gülek B
    Rev Assoc Med Bras (1992); 2021 Oct; 67(10):1491-1497. PubMed ID: 35018981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches.
    Sodagar A; Javed R; Tahir H; Razak SIA; Shakir M; Naeem M; Yusof AHA; Sagadevan S; Hazafa A; Uddin J; Khan A; Al-Harrasi A
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants.
    Chen M; Pekosz A; Villano JS; Shen W; Zhou R; Kulaga H; Li Z; Smith A; Gurung A; Beck SE; Witwer KW; Mankowski JL; Ramanathan M; Rowan NR; Lane AP
    J Clin Invest; 2024 Mar; 134(8):. PubMed ID: 38483537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant.
    Boscolo-Rizzo P; Tirelli G; Meloni P; Hopkins C; Madeddu G; De Vito A; Gardenal N; Valentinotti R; Tofanelli M; Borsetto D; Lechien JR; Polesel J; De Riu G; Vaira LA
    Int Forum Allergy Rhinol; 2022 Oct; 12(10):1273-1281. PubMed ID: 35286777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections.
    Andeweg SP; de Gier B; Eggink D; van den Ende C; van Maarseveen N; Ali L; Vlaemynck B; Schepers R; Hahné SJM; Reusken CBEM; de Melker HE; van den Hof S; Knol MJ
    Nat Commun; 2022 Aug; 13(1):4738. PubMed ID: 35961956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion.
    Purja S; Oh S; Kim E
    Front Neurol; 2022; 13():887164. PubMed ID: 35911902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PHEV infection: A promising model of betacoronavirus-associated neurological and olfactory dysfunction.
    Shi J; Li Z; Zhang J; Xu R; Lan Y; Guan J; Gao R; Wang Z; Lu H; Xu B; Zhao K; Gao F; He W
    PLoS Pathog; 2022 Jun; 18(6):e1010667. PubMed ID: 35759516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.